The findings that PPARα activation in animal models improves cognitive functions and reduces Aβ pathology by promoting autophagy and stimulating Aβ proteolysis underscore the necessity of thorough clinical validation of the effectiveness of PPARα agonists on AD [13]. Here, PPARA is linked to Alzheimer disease.